Audien Hearing Aids 2026 explores how the Audien Atom Hearing Aid delivers FDA-compliant OTC hearing care, advanced design, ...

Environmental antimicrobial resistance is turning rivers, soils, and even the air into hidden highways for "superbugs," ...

Discover the top 3 manufacturing mistakes CDMOs make and how to prevent them when scaling for next-generation oncology.

Silicone’s composition gives it a synthetic polymer structure with a silicon-oxygen backbone, making it more resistant to ...

With smart DMPK strategies, cross-domain collaboration, and strong CDMO support, companies are pushing past the challenges of ...

The U.S. Department of Agriculture's Food Safety and Inspection Service issued a No Objection Letter confirming the ...

Cold and flu medications are among around 2,000 products being recalled by the U.S. Food & Drug Administration over rat feces ...

Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

Health system pharmacists and clinicians are monitoring a wave of drug approvals expected throughout 2026, including first-in-class therapies and expanded uses of existing drugs with implications for ...

Here at MIT Technology Review we’ve been writing about the gene-editing technology CRISPR since 2013, calling it the biggest ...

Co-founded by Jennifer Doudna and Fyodor Urnov, the company intends to simultaneously develop many gene editing treatments for rare conditions by using the agency’s “plausible mechanism” pathway.